VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 127 filers reported holding VAXCYTE INC in Q3 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $556,906 | +15.1% | 10,924 | +12.7% | 0.00% | 0.0% |
| Q2 2023 | $483,969 | +57.2% | 9,691 | +18.0% | 0.00% | +100.0% |
| Q1 2023 | $307,786 | -13.4% | 8,212 | +10.8% | 0.00% | -50.0% |
| Q4 2022 | $355,501 | +115.5% | 7,414 | +7.8% | 0.00% | +100.0% |
| Q3 2022 | $165,000 | +55.7% | 6,876 | +41.4% | 0.00% | 0.0% |
| Q2 2022 | $106,000 | -11.7% | 4,864 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $120,000 | – | 4,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,457,300 | $54,619,604 | 23.40% |
| Pivotal bioVenture Partners Investment Advisor LLC | 693,039 | $25,975,102 | 10.70% |
| RA Capital Management | 7,291,254 | $273,276,200 | 6.19% |
| Kynam Capital Management, LP | 1,216,784 | $45,605,064 | 5.89% |
| GREAT POINT PARTNERS LLC | 659,211 | $24,707,228 | 4.85% |
| Frazier Life Sciences Management, L.P. | 1,397,405 | $52,374,739 | 3.79% |
| ACUTA CAPITAL PARTNERS, LLC | 120,500 | $4,516,340 | 3.33% |
| Ghost Tree Capital, LLC | 225,000 | $8,433,000 | 2.49% |
| Carlyle Group Inc. | 1,923,158 | $72,079,962 | 2.15% |
| Opaleye Management Inc. | 177,000 | $6,633,960 | 1.99% |